Future in vivo validation of CXCL5 actions on breast cancer cells at metastatic bone niches in breast cancer patients with metastatic disease will further support our ex vivo culture findings that led to the identification of CXCL5 as a mechanism of bone colonization. This evidence concerns the gene CXCL5 and breast cancer.